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Abstract
Gangliosides are expressed on plasma membranes throughout the body and enriched 
in the nervous system. A critical role for complex a- and b- series gangliosides in central 
and peripheral nervous system ageing has been established through transgenic 
manipulation of enzymes in ganglioside biosynthesis. Disrupting GalNAc- transferase 
(GalNAc- T), thus eliminating all a- and b- series complex gangliosides (with consequent 
over- expression of GM3 and GD3) leads to an age- dependent neurodegeneration. Mice 
that express only GM3 ganglioside (double knockout produced by crossing GalNAc- T−/− 
and GD3 synthase−/− mice, Dbl KO) display markedly accelerated neurodegeneration 
with reduced survival. Degenerating axons and disrupted node of Ranvier architecture 
are key features of complex ganglioside- deficient mice. Previously, we have shown 
that reintroduction of both a- and b- series gangliosides into neurons on a global 
GalNAcT−/− background is sufficient to rescue this age- dependent neurodegenerative 
phenotype. To determine the relative roles of a- and b- series gangliosides in this rescue 
paradigm, we herein reintroduced GalNAc- T into neurons of Dbl KO mice, thereby 
reconstituting a- series but not b- series complex gangliosides. We assessed survival, 
axon degeneration, axo– glial integrity, inflammatory markers and lipid- raft formation 
in these Rescue mice compared to wild- type and Dbl KO mice. We found that this 
neuronal reconstitution of a- series complex gangliosides abrogated the adult lethal 
phenotype in Dbl KO mice, and partially attenuated the neurodegenerative features. 
This suggests that whilst neuronal expression of a- series gangliosides is critical for 
survival during ageing, it is not entirely sufficient to restore complete nervous system 
integrity in the absence of either b- series or glial a- series gangliosides.
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1  | INTRODUC TION
Gangliosides are a family of sialic acid- containing glycosphingolipids 
expressed on the external leaflet of most eukaryotic cell plasma mem-
branes and highly enriched in nervous tissue (Yu et al., 2011). Whilst 
neural development and differentiation were the major functions his-
torically attributed to gangliosides, more recently an essential role in 
nervous system maintenance and stability has been reported (Sheikh, 
Sun, et al., 1999; Susuki, Baba, et al., 2007; Takamiya et al., 1996). 
GM3 is the first simple ganglioside synthesised by the addition of 
α2,3- linked sialic acid to a lactosylceramide core (Figure 2a). GM3 is 
then modified by the β1,4- N- acetylgalactosaminyltransferase 1 en-
zyme (B4galnt1 or GalNAc- T) or by the α- 2,8- sialyltransferase (GD3 
synthase, GD3s) enzyme to produce a- series or b- series gangliosides 
respectively. It is GM1 & GD1a from the a- series, and GD1b & GT1b 
from the b- series that form the majority of the gangliosides expressed 
in the normal nervous system. Transgenic manipulations of the key 
enzymes that disrupt the ganglioside biosynthesis pathway have been 
used to elucidate the physiological function of gangliosides and have 
by and large demonstrated a high degree of functional redundancy. 
Despite this redundancy, the increasing loss of heterogeneity in the 
overall complement of gangliosides in general enhances the neurode-
generative phenotype and mortality of mice, suggesting complex and 
subtle roles for different gangliosides in fine- tuning the nervous sys-
tem over the lifespan. As gangliosides are synthesised by step- wise 
addition of hexose sugars to the elongating glycan core by multiple 
enzymes, block of one biosynthetic step leads to overflow into alter-
native biosynthetic steps, leading to complex changes in ganglioside 
profiles that are as yet poorly understood. At the least severe end of 
the spectrum, GD3s−/− mice that lack b- series complex gangliosides and 
thus over- express a- series gangliosides have a normal lifespan with no 
overt neurodegenerative phenotype. However, these mice exhibit a 
regenerative deficiency suggesting a role for b- series gangliosides in 
neural repair (Okada et al., 2002). GalNAc- T−/− mice that express no 
complex gangliosides whilst over- accumulating the simple precur-
sor gangliosides GM2, GD3 and 9- O- acetyl GD3 have a near- normal 
lifespan but develop age- dependent demyelination, axonal degener-
ation and a loss of axo– glial integrity at the node of Ranvier (NoR)
(Sheikh, Sun, et al., 1999; Susuki, Baba, et al., 2007). Cross- breeding 
the GD3s−/− and GalNAc- T−/− transgenic strains results in double a- and 
b- series null mice with a consequent accumulation of GM3 (GM3- only, 
Dbl knockout [KO] mice, Table 1). These mice have a severe post- natal 
neurodevelopmental phenotype with seizures, paralysis and early 
death. Notably, the severity of the Dbl KO phenotype appears to dif-
fer among research groups, presumably owing to subtle differences 
acquired in the background C57BL/6 mouse strains on which the mice 
are maintained (Inoue et al., 2002; Kawai et al., 2001). Mice lacking all 
gangliosides including GM3 develop a severe and lethal phenotype 
following weaning (Yamashita et al., 2005). In the total absence of 
gangliosides, there is a loss of transverse bands at the paranodal junc-
tion (Yamashita et al., 2005), but the effect on the organisation at the 
NoR has yet to be described with GM3- only ganglioside expression. 
Mice double null for galactocerebroside (GalC) and myelin- associated 
glycoprotein (MAG), GalC−/− × MAG−/− (Marcus et al., 2002), or gan-
gliosides and sulfatides, GalNAc- T−/− × CST−/− (McGonigal et al., 2019), 
have a severe phenotype with rapid and profound neurodegeneration 
resulting in death soon after weaning, suggesting the necessity for 
gangliosides, galactolipids and their interactive ligands in axo– glial 
homeostasis. Humans with mutations in ganglioside biosynthesis 
enzymes GM3s or GalNAc- T similarly develop neurodevelopmental 
and neurodegenerative syndromes that fall into the severe end of the 
spectrum compared to mice, emphasising the importance of com-
plex ganglioside expression beyond ageing, at least in man (Boukhris 
et al., 2013; Simpson et al., 2004).
Complex gangliosides are abundantly expressed in the brain 
and peripheral nerves (Ogawa- Goto & Abe, 1998; Svennerholm 
et al., 1994; Takamiya et al., 1996; Vajn et al., 2013). The a- series 
complex gangliosides, GM1 and GD1a exhibit the greatest enrich-
ment in peripheral nerve axons and localisation at NoR (McGonigal 
et al., 2010; Sheikh et al., 1999; Susuki, Baba, et al., 2007). This 
correlates with the increased incidence of autoantibodies against 
these gangliosides in the axonal variant of the autoimmune periph-
eral neuropathy Guillain– Barré syndrome (Willison & Yuki, 2002), 
where the motor axons are targeted, especially at the NoR. Nodal 
disruption has been found in both axonal Guillain– Barré syn-
drome animal models and from human tissue (Griffin et al., 1996; 
McGonigal et al., 2010; Susuki, Rasband, et al., 2007), signifying 
a structural role for gangliosides at this highly specialised site. It 
has been proposed that gangliosides in lipid rafts promote axo– 
glial integrity through stabilisation of the key contactin- associated 
Wild type GD3s−/− × GalNAcT−/−
GD3s−/− × GalNAcT−/− 
Tg(neuronal)
Abbreviated nomenclature WT Dbl KO Rescue
GalNAc transferase expressed 
globally
GD3 synthase expressed globally
a- series ganglioside expression in 
neurons
b- series ganglioside expression in 
neurons
GM3 over- expression, globally
TA B L E  1   Comparison of ganglioside 
synthesising enzyme and lipid expression 
profiles among the three mouse 
genotypes used in this study
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protein (Caspr)/neurofascin 155 (NF155) adhesion molecule 
complex at the paranode (Sheikh, Sun, et al., 1999; Susuki, Baba, 
et al., 2007), and additionally are an axonal ligand for glial MAG 
(Collins et al., 1997; Schnaar & Lopez, 2009; Vinson et al., 2001). 
An intact paranodal axo– glial junction is essential for propa-
gation of action potentials by precluding current leakage at the 
NoR (Charles et al., 2002). GM1 ganglioside, in particular, has 
long been considered a key component of rafts and indeed the 
GM1 ligand, cholera- toxin B subunit, is widely used as a lipid raft 
marker (Merritt et al., 1994). In addition, a role for gangliosides in 
anchoring complement regulatory proteins in lipid rafts has been 
proposed as their absence may account for the up- regulation of 
neuroinflammatory markers in the Dbl KO mice resulting in inflam-
mation and neurodegeneration (Ohmi et al., 2009).
Recently, we have reported that reintroducing complex a- and 
b- series gangliosides specifically into neurons of global complex 
ganglioside deficient mice is sufficient to nearly normalise nervous 
system dysfunction and pathology (Yao et al., 2014). Notably, the 
same restorative effect was not attained by ganglioside reintro-
duction into glia, underscoring the functional importance of neu-
ronally located complex gangliosides. GD3s−/− mice lacking b- series 
gangliosides are considered to develop and age normally, and thus 
it might be argued that a- series gangliosides alone are the criti-
cal complex ganglioside constituents required for normal neural 
development and maintenance. However, these mice do display 
subtle abnormalities in nodal integrity and regeneration (Okada 
et al., 2002; Susuki, Baba, et al., 2007). In addition, in the absence 
of sulfatide, which is highly expressed on the glial membrane, 
we have previously shown that a- series gangliosides alone are 
insufficient to abrogate the lethal phenotype in GD3s−/− × CST−/− 
mice, suggesting b- series gangliosides are functionally important 
(McGonigal et al., 2019). To interrogate this further herein, we ex-
pressed a- series gangliosides selectively in neurons of GM3- only 
mice in the absence of b- series gangliosides to explore their critical 
role in more detail. Whilst reintroduction of a- series gangliosides 
in neurons largely restored survival and behavioural phenotype of 
GM3- only mice, this was insufficient to completely attenuate axon 
degeneration or nodal disruption, suggesting the requirement for 
glial, and/or b- series ganglioside expression for normal nervous 
system function and integrity.
2  | METHODS
2.1 | Mice
Wild type, GD3s−/− × GalNAc- T−/− and GD3s−/− × GalNAc- T−/−- 
Tg(neuronal) were used: for simplicity, these genotypes will henceforth 
be abbreviated to WT, Dbl KO and Rescue respectively. Original 
GalNAc- T−/− and GD3s−/− colonies were gifted from the Furakawa 
laboratory 20 years ago and maintained locally on a C57BL/6 
253 background (Harlan, UK). An overview of the expression of 
gangliosides in each genotype used in this study is outlined in 
Table 1. Group number and age are described in Figure 1 and per 
experiment below. No randomisation was performed to allocate 
subjects in the study. Dbl KO mice were produced as previously 
described (Inoue et al., 2002; Kawai et al., 2001) by crossing GD3s−/− 
(Okada et al., 2002) and GalNAc- T−/− (Takamiya et al., 1996) mice. 
Rescue mice, with reconstituted site- specific expression of a- series 
gangliosides in neurons were produced by crossing the GD3s−/− 
line with the recently reported GalNAcT−/−- Tg(neuronal) line (Yao 
et al., 2014). Enzyme activity assays have previously been performed 
in the GalNAcT−/−- Tg(neuronal) line and found to be lower than 
WT mice which we attributed to a dilution effect because of the 
analysis of whole brain rather than exclusively neuronal tissues (Yao 
et al., 2014; McGonigal et al., 2016). Mice were maintained under a 
12- hr light/dark cycle in controlled temperature and humidity with 
ad libitum access to food and water. Mice, of either sex, underwent 
killed by CO2 inhalation; all housing and experimental protocols 
were approved by and complied with UK Home Office guidelines, 
conformed to University of Glasgow institutional guidelines and 
performed under licence P0C6B3485.
F I G U R E  1   Experimental flow diagram. (a) WT n = 146, Dbl KOn = 43, Rescuen = 48. (b) Grip strength: WT n = 8 (8– 12 weeks), n = 10 
(24– 36 weeks), n = 11 (>52 weeks); Dbl KOn = 5 (8– 12 weeks), n = 13 (24– 36 weeks) n = 7 (>52 weeks); Rescuen = 7 (8– 12 weeks) n = 7 (24– 
36 weeks) n = 10 (>52 weeks). Rotarod: WT n = 8 (8– 12 weeks), n = 10 (24– 36 weeks), n = 11 (>52 weeks); Dbl KOn = 5 (8– 12 weeks), n = 13 
(24– 36 weeks), n = 7 (>52 weeks); Rescuen = 7 (8– 12 weeks), n = 7 (24– 36 weeks), n = 10 (>52 weeks). (c) n = 3– 4 per genotype. (d) n = 3 per 
genotype. (e) n = 3 per genotype
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2.2 | Materials
Monoclonal antibodies used to detect complex a- or b- series ganglio-
sides were generated by immunisation of ganglioside- deficient mice 
with ganglioside liposomes or ganglioside- mimicking Campylobacter 
jejuni lipo- oligosaccharide, as previously described (Boffey 
et al., 2005; Bowes et al., 2002). Anti- GM1 ganglioside antibody, DG2, 
and anti- GD1b antibody, MOG1, were used at 20 µg/ml in PBS. All 
other primary antibodies were used in a blocking solution (10% NGS 
+0.5% Triton X- 100 in PBS) as follows: mouse anti- phosphorylated 
neurofilament- H antibody (NF- H, BioLegend #801602 clone SMI31; 
RRID:AB_2715851; 1:2000); mouse anti- pan voltage- gated sodium 
F I G U R E  2   Neuronal expression of a- series gangliosides promotes survival and normal behaviour. (a) Ganglioside biosynthesis pathway. 
The GalNAc- T enzyme is necessary for generating complex gangliosides and the GD3s enzyme for production of b- series complex 
gangliosides. In mice null for both genes, Dbl KO mice, complex gangliosides and GD3 are not expressed (grey boxes). Constructs were 
generated to drive GalNAc- T expression in neurons of Dbl KO mice to produce the Rescue mouse line that have expression of a- series 
gangliosides restored neuronally (green box). (b) PCR results confirm the genotypes of the mice. The larger band and smaller band represent 
the disrupted GalNAc- T and GD3s genes with insert respectively. The flag identifies the reintroduction of the GalNAc- T gene into the 
neurons of Rescue mice. (c) Expression of a- and b- series gangliosides was confirmed by staining peripheral nerves with anti- GM1 and 
anti- GD1b monoclonal antibodies (green) respectively. Axons were identified with neurofilament (Nfil) antibody immunostaining (magenta). 
Scale bar =10 µm. (d) Survival plots demonstrate that Dbl KO mice (n = 43) develop normally and then show a progressive reduction in life 
expectancy which is halved at 18 weeks. Reconstituting a- series gangliosides neuronally in the Rescue mice (n = 48) results in a return to 
normal life expectancy similar to WT (n = 146). (e) Performance on the rotarod and grip strength is significantly poorer beyond 24 weeks of 
age in Dbl KO mice, and resolved to WT levels in Rescue mice. Rotarod: WT n = 8 (8– 12 weeks), n = 10 (24– 36 weeks), n = 11 (>52 weeks); 
Dbl KO n = 5 (8– 12 weeks), n = 13 (24– 36 weeks), n = 7 (>52 weeks); Rescue n = 7 (8– 12 weeks), n = 7 (24– 36 weeks), n = 10 (>52 weeks). 
Grip strength: WT n = 8 (8– 12 weeks), n = 10 (24– 36 weeks), n = 11 (>52 weeks); Dbl KO n = 5 (8– 12 weeks), n = 13 (24– 36 weeks) 
n = 7 (>52 weeks); Rescue n = 7 (8– 12 weeks) n = 7 (24– 36 weeks) n = 10 (>52 weeks). Two- way ANOVA, ***p < .001, **p < .01 *p < .05. 
Abbreviated nomenclature: Wild type (WT); GD3s−/− × GalNAcT−/− (Dbl KO); GD3s−/− × GalNAc- T−/−- Tg(neuronal) (Rescue)
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channel (pNav; Sigma- Aldrich #8809; RRID:AB_477552; 1:100); 
rabbit anti- Caspr (gifted by Professor Peles; Weizmann Institute; 
1:1,000); rabbit anti- pan neurofascin (pNFasc, gifted by Professor 
Brophy, University of Edinburgh; 1:1,000); mouse anti- ankyrin G 
(Thermo Fisher Scientific; RRID:AB_2533145; 1:100); mouse anti- 
MAG antibody (gifted by Professor Brophy, University of Edinburgh; 
1:100); rabbit anti- voltage- gated potassium channel 1.1 (Kv1.1, 
Alomone Laboratories #APC- 009; RRID:AB_2040144; 1:200); rab-
bit anti- NeuN antibody (Millipore; 1:750), rat anti- mouse F4/80 
(MCAP497; Serotec; 1:500) or FITC- labelled rabbit anti- C3c (Dako; 
1:300). Primary antibodies used in Western blots were rabbit anti- 
MAG 248 (gifted by Professor N. P. Groome, 1:10 000) and rabbit 
anti- pNFasc (gifted by Professor Brophy, University of Edinburgh; 
1:5,000), anti- Caspr (antibodies- online.com ABIN1304571, 1:1,000); 
anti- Flotillin (BD Bioscience 610,821, 1:1,000); rabbit anti- proteolipid 
protein (PLP/DM20, raised against common C- terminal residues 
271– 276 and gifted by Professor N.P. Groome, 1:100,000) prepared 
in 5% skimmed milk powder in TBS containing 0.1% Tween- 20 (T- 
TBS). Secondary antibodies were prepared in PBS plus 1% NGS: 
isotype- specific (IgG1, IgG3) Alexa Fluor 488- and 555- conjugated 
goat anti- mouse IgG antibodies (Invitrogen; RRID:AB_141780); Alexa 
Fluor 488- and Alexa Fluor 555- conjugated goat anti- rabbit antibod-
ies (Invitrogen; RRID:AB_141761). Secondary antibodies for western 
blots were HRP- linked goat anti- rabbit (Dako, 1:10 000) or goat anti- 
mouse (Dako, 1:5,000) prepared in 5% skimmed milk/T- TBS.
2.3 | Lipid localisation
Peripheral nerves were rapidly dissected from 6- month- old mice and 
snap frozen. Tissue sections (10 µm) were collected onto APES- coated 
slides. To detect the presence of a- and b- series gangliosides, sections 
were treated as previously described (McGonigal et al., 2019). 
Representative images were captured at 40× magnification using a 
Zeiss AxioImager Z1 with ApoTome attachment and processed using 
Zeiss Zen 2 blue edition software.
2.4 | Phenotypic analysis
Mice were monitored over their natural lifespan. Survival plots over 
a 28- week period comparing the three genotypes were generated 
(WT n = 146; Dbl KO n = 43; Rescue n = 48). Behavioural analysis was 
performed in the afternoon. Grip strength (WT n = 8 [8– 12 weeks], 
n = 10 [24– 36 weeks], n = 11 [>52 weeks]; Dbl KO n = 5 [8– 12 weeks], 
n = 13 [24– 36 weeks], n = 7 [>52 weeks]; Rescue n = 7 [8– 12 weeks], 
n = 7 [24– 36 weeks], n = 10 [>52 weeks]) and performance on a 
rotarod (WT n = 8 [8– 12 weeks], n = 10 [24– 36 weeks], n = 11 
[>52 weeks]; Dbl KO n = 5 [8– 12 weeks], n = 13 [24– 36 weeks], n = 7 
[>52 weeks]; Rescue n = 7 [8– 12 weeks], n = 7 [24– 36 weeks], n = 10 
[>52 weeks]) were assessed and statistically analysed as previously 
described (Yao et al., 2014). Briefly, mice were habituated to the 
rotarod apparatus and digital force gauge equipment (Chatillon 
DFIS; AMETEK) for 3 days prior to recording. Latency to fall from 
the rod rotating at a fixed speed of 15 rpm over a 100- s trial was 
recorded. Total tensile force generated from the front limbs was 
subtracted from the total force generated from all four limbs to 
calculate hindlimb grip strength. Each test was repeated three times 
each day over three consecutive days and the data averaged per 
mouse. Results were plotted as the average ±SEM.
2.5 | Ultrastructure
Mice (12 months, n = 3 per genotype) were killed by CO2 
inhalation then a post- mortem transcardial perfusion with 5% 
glutaraldehyde/4% paraformaldehyde mixture performed before 
the second segment of the cervical spinal cord was removed and 
processed for resin embedding as previously described (Griffiths 
et al., 1981). Sections were cut for ultrastructural analysis. Electron 
micrographs from transverse sections of the ventral columns of the 
spinal cord at 2700x magnification were captured on a Jeol 1,200 
Electron microscope. Quantification was performed as previously 
described (McGonigal et al., 2019). Results were plotted as the 
average ±SEM.
2.6 | Nerve protein immunoanalysis
Optic nerves, sciatic nerve and spinal cord were rapidly dissected 
from 6- month- old mice (n = 3/4 per genotype) into 4% PFA for 
30 min (nerves) and overnight (cord), respectively, at 4°C. Tissue 
was processed and stained as previously described (McGonigal 
et al., 2019). Briefly, optic nerve sections and teased sciatic nerve 
were incubated overnight in blocking solution with the following 
primary antibodies: mouse anti- pNav IgG1 antibody, rabbit anti- 
Caspr IgG antibody, rabbit anti- Kv1.1 IgG antibody, rabbit anti- 
pNFasc IgG antibody or mouse anti- MAG IgG1 antibody. Spinal cord 
sections were incubated overnight in blocking solution with either 
mouse anti- NeuN antibody, rat anti- F4- 80 antibody or rabbit anti- 
C3c- FITC antibody.
All images were captured with a Zeiss Z.1 AxioImager with 
ApoTome attachment or Zeiss LSM 880 microscope using Zeiss Zen 
2 blue edition software. Optic nerve pNav channel cluster number 
and MAG intensity analysis were performed as previously described 
(McGonigal et al., 2019). The total length of Caspr immunostaining 
per node (distance between dimer outer edges minus the gap be-
tween Caspr dimers) was quantified from four 25 × 25 µm fields of 
view per z- stack and averaged per animal. Total length of pNFasc 
immunostaining was performed similarly by simply measuring the 
distance between dimer outer edges. For peripheral nerve node 
analysis, images from teased sciatic nerve were used to quantify the 
distance between the Caspr dimers, the distance between Kv1.1 
dimers, the length of the Nav channel clusters, the length of the 
pNFasc domain and the total length of Caspr protein (as above) from 
20 to 50 NoR per genotype. For spinal cord, images of the ventral 
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horn (identified by DAPI) from three non- consecutive spinal cord 
sections were captured. The number of NeuN or F4/80- positive 
cells within three 50 × 50 µm ROI was quantified. Results were plot-
ted as the average ±SEM.
2.7 | Lipid raft preparation
Partitioning of proteins into lipid rafts was investigated according to 
the methodology of Schafer et al. (Schafer et al., 2004). Dissected 
brain tissue (6 months, n = 3 per genotype) was snap frozen in 
liquid nitrogen and stored at −80°C until required. Brain tissue was 
homogenised at 10 mgs/ml in homogenisation buffer (HB) composed 
of 0.32 M sucrose, 5 mM phosphate buffer pH 7.4, 0.5 mM PMSF, 
1 mM Na- orthovanadate, 1 mM Na- pyrophosphate and a protease 
inhibitor cocktail (Sigma, #P8340) using a Teflon homogeniser on 
medium speed. Homogenates were centrifuged at 600 g for 10 min 
at 4°C and supernatants then centrifuged at 45,000 g for 60 min at 
4°C. The membrane- enriched pellets were resuspended in HB and 
protein concentration determined using the BCA (bicinchoninic acid) 
method (Thermo Fisher Ltd). Detergent extraction was performed 
with 100 μg of protein in a final volume of 1 ml using an extraction 
buffer containing either 1% Triton X- 100 (NF155, Caspr & flotillin) 
or 1% CHAPS (MAG and PLP), 20 mM Tris- HCl pH 8.0, 150 mM 
NaCl, 10 mM iodoacetamide plus the inhibitors described for HB 
above. Samples were rotated at 4°C for 1 hr and then centrifuged at 
13,000 g for 60 min at 4°C. The detergent- soluble supernatant was 
removed and the detergent- insoluble pellet fraction resuspended in 
400- μl HB and stored at −20°C until required. We will now refer 
to the detergent- soluble supernatant and the detergent- insoluble 
pellet fractions throughout the manuscript where the detergent- 
insoluble pellet is the lipid raft containing fraction.
Sucrose density centrifugation was performed using the 
Beckman SW55 rotor. Resuspended detergent- insoluble pellets 
were mixed with 0.8mls of 2 M sucrose, layered with 1.6 mls 1 M 
sucrose, then layered with 1.2 mls 0.2 M sucrose and centrifuged at 
190,000 g for 19 hr at 4°C. Following centrifugation, 400- µl sucrose 
fractions were collected from top to bottom to give 10 fractions 
per sample. The protein content of each of the sucrose fractions 
obtained from the 1% Triton X- 100 detergent- insoluble pellet was 
precipitated with 5% trichloroacetic acid (TCA) and the TCA pel-
lets resuspended in denaturing buffer, 1% CHAPS fractions did not 
require precipitation. The integrity of the lipid rafts isolated using 
this protocol was confirmed by treating 1mg/ml of the membrane- 
enriched fraction with 0.2% saponin to disrupt cholesterol which 
is a requirement for raft formation (Cerneus et al., 1993; Rothberg 
et al., 1990). Samples were rotated in the presence of saponin for 
30 min at 4°C followed by centrifugation at 13,000 g for 10 min. The 
detergent extraction procedure detailed above was then performed 
on the pelleted membrane fraction, followed by centrifugation to 
generate the detergent- soluble supernatant and the detergent- 
insoluble pellet which were stored at −20°C until required.
2.8 | Western blot analysis
Western blot was performed as described previously (McGonigal 
et al., 2019). In brief, samples were subjected to SDS- PAGE using 
BioRad criterion 4%– 20% gels with MOPS buffer, transferred 
to nitrocellulose using the Iblot system and all blocking and 
antibody reactions performed using 5% skimmed milk T- TBS. 
Immunocomplexes formed with a HRP coupled secondary antibody 
were detected using the ECL method and scanned X- ray films were 
analysed using Image J (NIH) software.
2.9 | Experimental design and statistics
This study was an exploratory characterisation with no pre- 
determined exclusion criteria. A graphical flow chart of study 
design is shown in Figure 1. The numbers of independent animals 
are described in the Materials and Methods sections, and no 
sample calculation was performed. The experimenter performing 
analysis was unaware of the genotype. Statistical differences among 
genotypes were determined by one- way or two- way ANOVA 
followed by a Fisher's or Tukey's post hoc test using GraphPad 
Prism 6 software (RRID:SCR_002798). Data were not assessed for 
normality, ROUT tests for outliers were applied and no data points 
were excluded. Differences were considered significant when 
p < .05. This study was not pre- registered.
3  | RESULTS
3.1 | Neuronal a- series ganglioside expression 
promotes survival and a normal phenotype
Dbl KO mice that express only the simple ganglioside GM3 have 
a reduced lifespan and exhibit a neurodegenerative phenotype. 
To assess whether neuronal expression of a- series gangliosides 
is sufficient to rescue this phenotype, we generated Rescue mice 
that selectively express complex a- series gangliosides in neurons 
by backcrossing the GD3s−/− transgenic mouse strain (Inoue 
et al., 2002; Kawai et al., 2001; Takamiya et al., 1996) with the 
GalNAcT- Tg(neuronal) line (Yao et al., 2014). Targeted gene disruption 
and reintroduction in these transgenic lines were confirmed by PCR 
and screening for complex ganglioside expression in neural tissue by 
immunostaining (Figure 2). GalNAc- T and GD3s genes are disrupted 
by an insert, which was assessed by PCR. In Figure 2b, the larger 
slower migrating GalNAc- T band and smaller faster migrating GD3s 
bands represent appropriate disruption in both transgenic mice 
compared to WT. In addition, a band identifying the GalNAc- T- 
flag in the Rescue mouse strain confirms selective GalNAc- T gene 
expression neuronally (Figure 2b).
To demonstrate selective ganglioside expression profiles on neu-
ral membranes among the genotypes, transverse peripheral nerve 
sections were probed with anti- ganglioside antibodies targeting 
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either GM1 (a- series) or GD1b (b- series) (Figure 2c). Both anti- GM1 
and - GD1b antibodies bound strongly to WT peripheral nerve bun-
dles, confirming the presence of both a- and b- series gangliosides. 
Immunoreactivity was absent from nerve sections from Dbl KO mice, 
confirming specific loss of complex gangliosides from both the a- and 
b- series. Restoration of a- series and not b- series ganglioside expres-
sion was indicated by positive immunostaining for anti- GM1, and not 
anti- GD1b antibody, in Rescue mice. Similar results were obtained 
using an antibody targeting GD1a (data not shown).
Behaviourally, the Dbl KO mice displayed a tremor that worsened 
with age, and sudden death of unknown cause from 4 weeks of age 
onwards. Seizures were never observed, although mice were not 
constantly under video surveillance. A Kaplan– Meier survival plot 
demonstrated a significant difference among genotypes in survival 
rate over 28 weeks (p < .001, Figure 2d). Only 42% of Dbl KO mice 
survive to the end point of this study compared to a survival rate 
of 96% in wild- type mice. These findings are similar to those of a 
previous study in which only 33% Dbl KO mice survived at 30 weeks 
(Inoue et al., 2002). The presence of neuronal a- series gangliosides 
was sufficient to increase the proportion of mice surviving to 88%, 
which was not significantly different to WT. The age- dependent 
behavioural performance of mice was compared among genotypes 
(Figure 2e). Both rotarod performance and grip strength showed 
no significant difference among genotypes at 8– 12 weeks. A sig-
nificantly poorer performance on rotarod, determined by reduced 
latency to fall within the given trial period, was recorded at both 
24– 36 weeks and >52 weeks of age in Dbl KO mice compared to WT 
and Rescue mice (24– 36 weeks, p < .001, 41.2 ± 9.7 vs. 86.2 ± 6.6%, 
p < .001 41.2 ± 9.7 vs. 92.7 ± 4.1%; >52 weeks, p < .001, 16.2 ± 6.4 
vs. 84.7 ± 7.1%, p < .001 16.2 ± 6.4 vs. 64.2 ± 9.3%). Similarly, a sig-
nificantly weaker grip strength was recorded at both 24– 36 weeks 
and >52 weeks of age in Dbl KO mice compared to WT and Rescue 
mice (24– 36 weeks p < .001, 0.73 ± 0.01 vs. 1.22 ± 0.05, p < .01 
0.73 ± 0.01 vs. 1.13 ± 0.08 N; >52 weeks p < .001, 0.74 ± 0.17 vs. 
1.16 ± 0.09, p < .05 0.74 ± 0.17 vs. 1.03 ± 0.03 N). The performance 
on rotarod and grip strength was not significantly different between 
WT and Rescue mice at any age, indicating that a- series ganglioside 
expression can restore Dbl KO mice to the performance level of WT.
3.2 | Neuronal expression of a- series gangliosides 
attenuates neurodegeneration and immune activity in 
Dbl KO CNS
Previous qualitative studies report that loss of some or all complex 
gangliosides leads to peripheral axon degeneration. Whilst this has 
been observed it has not previously been quantified in Dbl KO mice 
(Inoue et al., 2002). Ultrastructural analysis of the cervical spinal 
cord from 12- month- old Dbl KO animals demonstrated a significant 
increase in the number of degenerating axons, both hyperdense and 
those with an accumulation of abnormal cytoskeletal organelles 
compared to WT tissue (16 949 ± 979/mm2 vs. 169 ± 169/mm2, 
Figure 3a, one- way ANOVA, p < .001). Restoration of neuronal 
a- series ganglioside expression in Rescue mice led to a significant 
reduction in degenerating axons (6,215 ± 1494/mm2). While 
significantly lower than Dbl KO mice, the number remained greater 
than WT, suggesting a partial rescue of this feature and the potential 
need for b- series gangliosides for full rescue as shown in GalNAcT−/−- 
Tg(neuronal) mice (Yao et al., 2014). Splitting of the myelin sheath was 
a feature of both Dbl ko and Rescue animals (indicated by arrowheads 
Figure 3a). To determine if the loss in CNS degenerating axon 
number corresponded to a loss in the number of NoR, we quantified 
Nav clusters flanked by Caspr dimers (representative images of 
immunostaining shown in Figure 4c). In the optic nerve, Nav cluster 
number was reduced in Dbl KO mice compared to WT (53.4 ± 0.77 
vs. 72.4 ± 5.58, Figure 3a, one- way ANOVA, p =.07) and restored to 
WT levels in the Rescue mice (75.9 ± 8.44 vs. 72.4 ± 5.58, Figure 3a, 
one- way ANOVA, p =.07). These results do not reach significance 
but indicate a subtle reduction in nodes in response to complex 
ganglioside loss. Previous studies have shown that mice with limited 
ganglioside expression have a reduced number of motor neurons 
and increased F4/80 immunoreactivity and complement deposits 
in their lumbar spinal cord and cerebellum with age (Ohmi et al.,. 
,2009, 2014). We set out to replicate these findings and determine 
if this could be reversed with the reintroduction of neuronal a- series 
ganglioside expression. Immunostaining for the neuronal marker 
NeuN showed a reduction in the number of positive motor neurones 
in the ventral horn of the cervical cord in Dbl KO mice compared to 
WT (17 ± 2 vs. 28 ± 1 cells/ROI, one- way ANOVA p < .05, Figure 3b). 
The number of NeuN- positive neurons increased when a- series 
gangliosides were reintroduced (23 ± 3 cells/ROI) but this did not 
reach significance compared to Dbl KO cord and simultaneously 
was not significantly reduced compared to WT, suggesting a partial 
rescue. The number of F4/80- positive cells, suggesting microglial 
activation, increased significantly in Dbl KO mice compared to WT 
(22 ± 4 vs. 10 ± 1 cells/ROI, one- way ANOVA p < .05, Figure 3b), 
and while Rescue mice had fewer positive cells (11 ± 3 cells/ROI), 
again this did not reach significance compared to either of the other 
genotypes. As had been previously reported by Ohmi et al. (2014), 
we observed an increase in immunoreactivity for complement (C3c) 
in Dbl KO spinal cord compared to WT. This immunoreactivity was 
qualitatively attenuated in the spinal cords from Rescue mice.
3.3 | Loss of CNS axo– glial integrity in Dbl 
KO mice is attenuated by neuronal a- series 
ganglioside expression
Complex ganglioside deficiency has been associated with age- 
dependent nodal disorganisation in myelinated fibres suggesting a 
role in stability and maintenance of this specialised site (Susuki, Baba, 
et al., 2007). This has not previously been investigated in Dbl KO mice, 
thus we characterised the nodal disorganisation of Dbl KO mice, and 
the role of neuronal a- series ganglioside expression in normalising this. 
In the CNS (optic nerve), the total length of pan- neurofascin (pNFasc) 
immunostaining (comprising both nodal NF186 and paranodal NF155 
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domains) was significantly reduced in Dbl KO mice compared to WT 
(2.4 ± 0.39 vs. 4.7 ± 0.23, Figure 4a, one- way ANOVA, p < .01). In all 
mice, the staining for NF186, defined by co- localisation with the nodal 
marker AnkyrinG, appeared strong and unaltered. Whilst paranodal 
NF155 staining was observed in Dbl KO mice (indicated by white 
arrowheads), many nodes consisted only of nodal NF186 staining 
(indicated by open arrowheads), thus accounting for the reduction 
in average pNFasc domain length. The length of pNFasc staining 
was recovered to within the range of WT length in Rescue mice and 
was significantly longer than Dbl KO mice (3.8 ± 0.04 vs. 2.4 ± 0.39, 
one- way ANOVA, p < .05). Similarly, total Caspr domain length was 
significantly reduced in Dbl KO mice compared to WT (2.9 ± 0.2 vs. 
3.5 ± 0.05 µm, Figure 4c, one- way ANOVA, p < .05). The loss of staining 
most prominently occurred at the paranodal/juxtaparanodal border 
(open arrowheads, Figure 4c). However, unlike pNFasc, the length 
remained truncated in the Rescue compared to WT mice (2.8 ± 0.05 
vs. 3.5 ± 0.05 µm, Figure 4c, one- way ANOVA, p < .05). Nav clusters 
occasionally appear lengthened in Dbl KO mice (white arrowheads).
F I G U R E  3   An increase in neurodegeneration and immune markers found in the CNS of 12- month- old Dbl KO mice is reversed by the 
expression of neuronal a- series gangliosides. (a) When a- series ganglioside expression is restored in Rescue cervical spinal cord, the number 
of degenerating axons significantly decreases compared to Dbl KO mice, but remains increased compared to WT, indicating a partial rescue 
of this feature. Representative micrographs are shown for each genotype; white arrowheads indicate myelin splitting. The number of mature 
nodes of Ranvier (NoR, voltage- gated sodium channel [Nav] clusters flanked by Caspr dimers, see Figure 4c for representative images) was 
reduced in 6- month CNS optic nerves of Dbl KO mice, however, this did not reach significance. This number was restored to WT levels by 
restoration of a- series gangliosides in neurons of Rescue mice. (b) The number of NeuN- positive neurons is reduced, and F4- 80- positive cells 
is significantly increased in the cervical spinal cord ventral horn (VH) in Dbl KO mice compared to WT. Reconstitution of a- series ganglioside 
expression in Rescue mice partially restores these parameters to WT levels. C3c reactivity is observed in Dbl KO mice spinal cord. One- 
way ANOVA, * indicates significance compared to WT and # indicates significance compared to Rescue, *p < .05, ***p < .001, n = 3 mice/
genotype. Scale bar =5 µm (a) and 10 µm (b). Abbreviated nomenclature: Wild type (WT); GD3s−/− × GalNAcT−/− (Dbl KO); GD3s−/− × GalNAc- 
T−/−- Tg(neuronal) (Rescue)
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F I G U R E  4   Age- dependent disturbance of CNS axo– glial integrity in Dbl KO mice is partially restored by neuronal a- series ganglioside 
expression. (a) Mature nodes of Ranvier (NoR) are identified by AnkyrinG clusters (blue) flanked by pan- neurofascin (pNFasc) dimers 
(orange). Total length of pNFasc (detects both nodal NF186 and paranodal NF155 isoforms) immunostaining in 6- month- old optic nerves is 
significantly reduced in Dbl KO mice, and restored to WT levels with neuronal a- series ganglioside expression in Rescue mice. In Dbl KO mice, 
presumed NF155 can be identified (white arrowheads), but often only presumed NF186 is present (open arrowhead). (b) Sucrose density 
gradient analysis of the TX- 100 detergent- insoluble (D. Insol) fraction of brain membrane homogenate revealed no change in the lipid raft 
association of NF155 in Dbl KO or Rescue mice compared to WT. (c) Mature NoR are identified by pan voltage- gated sodium channel (pNav) 
clusters (green) flanked by paranodal Caspr dimers (magenta) in optic nerve. Total length of Caspr immunostaining is reduced in 6- month- old 
optic nerves of both Dbl KO and Rescue mice. Open arrowheads indicate shortening of Caspr staining at the paranodal/juxtaparanodal edge, 
and white arrowheads indicate examples of lengthened pNav cluster staining. (d) In WT brain membrane homogenate, Caspr was present 
in the detergent- soluble and detergent- insoluble fractions following extraction in TX- 100 detergent, whereas almost all Caspr from Dbl KO 
and Rescue mice was found in the detergent- soluble fraction. Blots show that raft- associated Flotillin protein was mostly resistant to TX- 100 
extraction and present in all genotypes. One- way or two- way ANOVA, *p < .05, **p < .01, n = 3– 4 mice/genotype. Scale bars =5 µm (a) and 
20 µm (b). Abbreviated nomenclature: Wild type (WT); GD3s−/− × GalNAcT−/− (Dbl KO); GD3s−/− × GalNAc- T−/−- Tg(neuronal) (Rescue)
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Caspr and NF155 are tethered to detergent- insoluble lipid 
rafts and thought to be required for maintenance of paranodal ar-
chitecture. Previous reports have shown disruption of lipid raft 
microdomains in the absence of gangliosides leading to an interrup-
tion in axo– glial integrity at the paranodal junction (Susuki, Baba, 
et al., 2007). Lipid rafts are a heterogeneous mixture of the lipids that 
associate with various proteins to generate an ordered membrane 
structure that can resist solubilisation by detergents. In this study, 
we employ a detergent extraction procedure followed by centrifuga-
tion that separates the lipid raft containing detergent- insoluble pel-
let from the detergent - soluble supernatant. The detergent- insoluble 
pool will contain proteins associated with lipid rafts but also protein 
aggregates and complexes that can resist detergent solubilisation. 
The detergent- soluble fraction will be composed of proteins asso-
ciated with small cellular micelles. The proteins associated with lipid 
rafts can be further purified from the detergent- insoluble fraction 
by sucrose density ultracentrifugation because of the lipid- mediated 
low- density, positive buoyancy of the rafts that causes floatation 
to the low- density sucrose fractions. To test if loss of all ganglio-
sides but GM3 causes raft disruption, we investigated the distribu-
tion of selected proteins in the detergent- soluble fraction and the 
detergent- insoluble fractions. The raft integrity was confirmed by 
pre- treatment with saponin to disrupt the cholesterol association 
with rafts and prevent the resistance to detergent solubilisation 
and therefore the floatation of selected proteins (NF155 and MAG) 
during sucrose ultracentrifugation (Figure S1a). Two detergent sys-
tems were used based on previous studies that have characterised 
their raft properties: Triton X- 100 for Caspr, NF155 and flotillin 
(Ohmi et al., 2011; Susuki, Baba, et al., 2007) and CHAPS for the 
myelin- associated proteins PLP and MAG (Taylor et al., 2002). For 
NF155, Flotillin and MAG, a significant proportion of the total pool 
was present in the detergent- insoluble lipid raft containing fraction 
in all three genotypes (Figures 4b,d & 5b). However, while Caspr was 
present in the detergent- insoluble fraction in WT, it was not detected 
in the Dbl KO and Rescue genotypes (Figure 4d). This was not due to 
a global loss of Caspr as the protein was detected in the non- raft- 
associated detergent- soluble fraction in all genotypes (Figure 4d).
A more sensitive analysis was then performed using a floatation 
assay sucrose density centrifugation to isolate the lipid raft pool as 
a result of their lipid association mediated buoyancy properties. The 
intensity of the target protein detected in 10 fractions, collected 
from low to high sucrose density, is expressed as a % relative to 
the total intensity across all fractions. The profile for NF155 for 
each genotype displayed a shoulder in fractions 4– 5 with a peak in 
abundance in fraction 6 (Figure 4b). There was no detectable differ-
ence between the genotypes in the distribution of NF155. Higher 
density fractions 7 onwards had detectable NF155 and NF186 re-
activity. As NF186 does not fulfil the criteria for raft association 
(Schafer et al., 2004), these fractions are not regarded as lipid rafts. 
The profile for MAG was similar among WT, DblKO and Rescue mice 
with a peak abundance in fraction 4 for all genotypes (Figure 5a). 
Interestingly, we observed that the amount of MAG present in the 
non- raft detergent- soluble fraction was lower in ganglioside Dbl KO 
and Rescue genotypes relative to WT (Figure 5b). To gain greater 
F I G U R E  5   Lipid raft- associated 
myelin- associated glycoprotein (MAG) is 
not perturbed in Dbl KO mice but total 
brain levels are reduced. (a) Sucrose 
density gradient analysis of the CHAPS 
detergent- insoluble fraction of brain 
membrane homogenate revealed no 
change in the lipid raft association of 
MAG in Dbl KO or Rescue mice compared 
to WT. (b) MAG levels do not change 
in the detergent- insoluble fraction 
from brains among genotypes, but are 
reduced in the detergent- soluble fraction 
from both Dbl KO and Rescue mice. (c) 
A decrease in MAG (green) intensity is 
observed in optic nerve sections from 
Dbl KO mice and returns to WT levels 
with neuronal expression of a- series 
gangliosides in Rescue mice. One- way 
or two- way ANOVA, *p < .05, n = 3– 4 
mice/genotype. Scale bar =10 µm. 
Abbreviated nomenclature: Wild type 
(WT); GD3s−/− × GalNAcT−/− (Dbl KO); 
GD3s−/− × GalNAc- T−/−- Tg(neuronal) (Rescue)
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insight into the effect of complex ganglioside loss on the ganglioside 
ligand MAG, we assessed axo– glial MAG distribution by staining in-
tensity in optic nerve sections. MAG intensity showed a reduction in 
Dbl KO mice compared to WT that was partially resolved in Rescue 
mice (26.4 ± 2.8 vs. 46.3 ± 5 vs. 46 ± 10.4 AU, Figure 5c, one- way 
ANOVA, p < .05, no significance in post- hoc multivariate compari-
sons). We also analysed PLP, a major compact myelin protein in one 
preparation and found that the raft profile was comparable for all 
three genotypes (Figure S1b).
Flotillin, which is regarded as a marker for lipid rafts, did dis-
play a rightward shift in the Dbl KO mice with a significantly lower 
proportion in fraction 4 when directly compared to WT (Figure S1c). 
However, when all three genotypes were compared, there was no 
difference among the flotillin profiles as Rescue displays interme-
diate properties. A high proportion of Caspr was detected in the 
raft- associated fractions from WT mice; however, only a very weak 
unmeasurable signal was detected in the Dbl KO and Rescue geno-
types (Figure S1d). Taken together, the data suggest that there may 
be a discrete disruption of selected rafts present in distinct cellular 
membranes; there is a disruption to raft association in axonal pro-
teins, but no major disruption of the rafts associated with the glial 
paranodal junction.
F I G U R E  6   Age- dependent disturbance of PNS axo– glial integrity in Dbl KO mice is partially restored by neuronal expression of a- series 
gangliosides. (a) Total pan- neurofascin (pNFasc) immunostaining length (magenta, detects nodal NF186 and paranodal NF155) decreased in 
6- month- old Dbl KO sciatic nerve nodes of Ranvier (NoR) and recovered with neuronal a- series ganglioside expression in Rescue nerve. Loss 
of staining was observed at the paranodal/juxtaparanodal edge (arrowheads). (b) A decrease in the length of gap between voltage- gated 
potassium channel (Kv1.1) dimers (white), indicating paranodal invasion, is observed in sciatic nerve from Dbl KO mice and returns to WT 
levels with neuronal expression of a- series gangliosides in Rescue mice. (c) A reduction in total Caspr staining length (orange) and lengthened 
pan voltage- gated sodium channel (pNav) clusters (green) was observed at sciatic nerve NoR from 6- month- old Dbl KO mice. Weaker Caspr 
staining at the juxtaparanodal edge of the paranode is indicated by arrowheads. Total Caspr length was normalised in Rescue mice and 
Nav cluster length further increased with restoration of neuronal a- series gangliosides. One- way ANOVA, *p < .05, **p < .01***p < .001, 
n = 3 mice/genotype. Scale bars = 5 µm (A&B) and 10 µm (c). Abbreviated nomenclature: Wild type (WT); GD3s−/− × GalNAcT−/− (Dbl KO); 
GD3s−/− × GalNAc- T−/−- Tg(neuronal) (Rescue)
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3.4 | Disruption of PNS axo– glial integrity in 
Dbl KO mice is reversed by neuronal a- series 
ganglioside expression
In the PNS, GM3- only expression in Dbl KO mice resulted in a re-
duction in total pNFasc length, particularly at the paranodal/jux-
taparanodal border compared to WT (7.8 ± 0.5 vs. 9.4 ± 0.5 µm, 
Figure 6a, one- way ANOVA, p < .05). Neuronal a- series ganglio-
side expression reversed the reduction in length to within the WT 
range in Rescue mice and was significantly lengthened compared 
to Dbl KO (10.1 ± 0.2 vs. 7.8 ± 0.5 µm, Figure 6a, one- way ANOVA, 
p < .05). This paranodal axo– glial disturbance was reflected by 
the reduction in distance between juxtaparanodal Kv1.1 dimer 
domains, suggestive of paranodal invasion owing to an impaired 
axo– glial junction. The gap between Kv1.1 dimers became sig-
nificantly reduced in Dbl KO mice, and was restored within the 
range of WT values in Rescue nerve (5.3 ± 0.3 vs. 10.05 vs. 0.8 vs. 
8.5 ± 0.3 µm, Figure 6b, one- way ANOVA, p < .01). Caspr length 
significantly decreased in Dbl KO mice compared to WT, and, un-
like CNS tissue, this length was partially restored with a- series 
ganglioside expression (6.4 ± 0.3 vs. 8.97 ± 0.4 vs. 8.2 ± 0.8 µm, 
Figure 6c, one- way ANOVA, p < .05). A lengthening of Nav clus-
ters in Dbl KO mice compared to WT was observed. This did not 
reach significance, however, the length was significantly greater 
in Rescue mice compared to WT and Dbl KO mice (1.29 ± 0.03 vs. 
1.42 ± 0.08 vs. 1.74 ± 0.14, Figure 6c, one- way ANOVA, p < .05), a 
phenomenon we also observed in the GalNAcT−/−- Tg(neuronal) mice 
(Yao et al., 2014). Reduction in length of Caspr immunostaining, 
because of a loss at the juxtaparanodal border of the paranode, is 
indicated by arrowheads.
4  | DISCUSSION
The role of individual gangliosides in neurodegeneration has been 
interrogated by transgenic manipulations at different stages in the 
biosynthesis pathway (Yu et al., 2011), but less is known about 
the contribution of more precise cellular membrane expression on 
phenotypes. GM1 & GD1a (a- series) and GD1b & GT1b (b- series) 
normally comprise the majority of nervous system gangliosides. 
We have previously shown that neuronal expression of these 
complex gangliosides is critical (Yao et al., 2014). Here, on the 
Dbl KO background, we reintroduced neuronal expression of the 
GalNAc- T gene to characterise the importance of a- series ganglioside 
expression selectively on neuronal membranes. Using behavioural, 
ultrastructural, immunohistological and biochemical methods, we 
compared the nervous system integrity of Dbl KO, Rescue and WT 
mice.
We show that neuronal a- series ganglioside expression is both 
necessary and sufficient for survival and normal behaviour. The 
essential role for gangliosides in sustaining life is indicated by 
early death in complete ganglioside- deficient mice (Yamamoto 
et al., 1996; Yoshihara et al., 2018), as is also seen in humans (Boukhris 
et al., 2013; Simpson et al., 2004). Survival in mice improves in Dbl 
KO mice, that express the simple ganglioside GM3, compared with 
complete ganglioside deficiency, but still does not result in a nor-
mal lifespan as we here, and others have shown (Inoue et al., 2002; 
Kawai et al., 2001). Early death has been attributed to lethal seizures 
and a neurodegenerative pathology incompatible with life. Selective 
reintroduction of complex gangliosides in neurons, but not glia, can 
attenuate age- dependent neurodegeneration found in GalNAc- T−/− 
mice (Yao et al., 2014), but it remains unknown if both a- and b- series 
gangliosides are essential. Considering GD3s−/− mice that solely 
express a- series gangliosides appear pathophysiologically normal 
(Okada et al., 2002), we surmised that a- series gangliosides are criti-
cal. In terms of survival, our results confirm that a- series ganglioside 
expression is sufficient; however, it is not possible to generate an 
exclusively b- series expressing mouse strain to ascertain their inde-
pendent role.
In the Dbl KO strain, we have performed a detailed analysis of 
neurodegeneration and axo– glial integrity, and assessed the role of 
neuronally expressed a- series gangliosides in relation to these fea-
tures. It was first reported that the absence of complex gangliosides 
led only to subtle nervous system defects (Takamiya et al., 1996), but 
the role of gangliosides in fine- tuning the nervous system is becom-
ing better appreciated. The important role for complex gangliosides 
in maintaining nervous system integrity was first reported in an en-
suing study by Sheikh, Sun, et al., (1999) who demonstrated myelin 
defects and axon degeneration in GalNAc- T−/− mice. In Dbl KO mice, 
peripheral nerve degeneration has been indicated, but not formally 
quantified (Inoue et al., 2002). Loss of neurons and up- regulation 
of inflammatory markers were previously reported in Dbl KO mice 
and provide a useful point of comparison in the current study (Ohmi 
et al.,. ,2009, 2014). Here, we performed an analysis of cervical spi-
nal cord degenerating axons and found that there was a significant 
increase in the number of degenerating fibres compared to WT, 
which was partially rescued by neuronal a- series ganglioside expres-
sion. Myelin remained qualitatively abnormal in the presence of neu-
ronal a- series gangliosides, which we interpret as a need for complex 
ganglioside expression in myelin or for a b- series- associated axonal 
ligand. Lipid raft association of myelin protein PLP remained normal 
suggesting this did not contribute to the observed myelin sheath 
splitting. In our Dbl KO mice, we reproduced the results reporting a 
reduction in spinal cord motor neuron number and show that once 
again the Rescue strain follows a similar pattern of partial recovery. 
This correlates with the increased number of degenerating axons, 
reduction in NoR and poor performance in behavioural tests assess-
ing motor function. To uncover a mechanism for neurodegeneration, 
Ohmi et al. (2009) studied inflammatory and complement compo-
nents in the brain of Dbl KO mice. Ganglioside deficiency in Dbl KO 
mice leads to the up- regulation of complement components in the 
brain, which the authors attributed to the dispersion of the comple-
ment regulators DAF and CD59 from lipid rafts. This was followed 
by consequent dysregulation of inflammatory mediators presumed 
to contribute to neurodegeneration. We too observed an increase in 
immunostaining for the inflammatory markers F4- 80 and C3c in the 
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spinal cords from Dbl KO mice that was reversed by neuronal a- series 
ganglioside expression, lending support to the original observation; 
however, a more in- depth analysis would be required to fully un-
derstand the mechanism. Together these data show that neuronal 
a- series gangliosides can compensate for deficiencies and protect 
the nervous system to a sufficient degree that function is possible 
despite an incomplete return to WT levels, and that b- series ganglio-
sides are required for complete normality.
NoR are essential for efficient nerve conduction and survival, 
and ganglioside expression is closely linked to this site (De Angelis 
et al., 2001; McGonigal et al., 2010; Sheikh, Deerinck, et al., 1999; 
Susuki, Baba, et al., 2007). Susuki, Baba, et al., (2007) were the first 
to demonstrate that aged GalNAc- T−/− mice display a disruption to 
the axo– glial junction at the paranode, and subsequent impairment 
in nerve function. There was a significant invasion of juxtaparan-
odal Kv domains into the PNS and CNS paranodes, and an additional 
shortening of the Caspr and NF155 paranodal protein domains in the 
CNS, demonstrating a breakdown of the axo– glial junction. This was 
similar though less pronounced, to the disruption observed in paran-
odal protein, sulfatide or GalC- deficient mice (Bhat et al., 2001; 
Boyle et al., 2001; Dupree et al., 1999; Ishibashi et al., 2002; Marcus 
et al., 2006; Tait et al., 2000). These results pointed towards a crucial 
role for complex gangliosides in maintenance of axo– glial integrity. 
Specifically, the authors suggested a critical role for a- series gangli-
osides as GD3s−/− mice show significantly less disruption. Previously, 
we replicated these results in GalNAc- T−/− mice, and additionally 
demonstrated that selectively expressing both a- and b- series com-
plex gangliosides on neuronal, but not glial, membranes was enough 
to largely reverse this nodal pathology (Yao et al., 2014). Nodal dis-
ruption has not previously been investigated in Dbl KO mice, but the 
expectation was that nodal pathology would be similar or more se-
vere than GalNAc- T−/− mice in the additional absence of GD3 since 
complete ganglioside- deficient mice have no transverse bands at 
the paranodal axo– glial junction (Yamashita et al., 2005). We found 
that both in the CNS and PNS, there was a loss or dispersion of 
Caspr and NF155 immunostaining at the juxtaparanodal edge of the 
paranode suggesting a breakdown in lateral paranodal axo– glial in-
tegrity, which was slightly more severe in the PNS than observed for 
GalNAc- T−/− mice. In the PNS, we observed an invasion of juxtaparan-
odal Kv1.1 channel clusters into the paranode and a lengthening of 
the Nav domain. Taken together, these data suggest that GM3 is not 
sufficient to maintain axo– glial integrity, particularly at the lateral 
paranode in Dbl KO mice.
Normal NF155 immunolocalisation was restored by neuronal 
a- series ganglioside expression in the CNS and PNS of Rescue mice; 
however, Caspr immunostaining was not improved in the CNS and 
only partially in the PNS. To independently validate our immunos-
taining data, we performed lipid raft analysis. Caspr and NF155 
are interacting proteins (Charles et al., 2002) known to be stabi-
lised in paranodal lipid rafts (Ogawa & Rasband, 2009) and their 
association with lipid raft fractions is impaired by complex gangli-
oside deficiency (Susuki, Baba, et al., 2007). Therefore, we studied 
whether lipid raft instability was exacerbated in Dbl KO mice and 
the role of neuronally expressed a- series gangliosides in recovering 
this. In this study, we show that lipid rafts are disrupted by gan-
glioside deficiency in Dbl KO mice based on a shift of the lipid raft 
marker flotillin out of the low- density raft- associated fractions, as 
previously shown (Ohmi et al., 2009). CNS NF155 lipid raft asso-
ciation did not appear perturbed in Dbl KO or Rescue brains. It is 
noteworthy that previously only ~20% of NF155 from the pure 
white matter optic nerve tract, displayed characteristics of lipid 
raft association (Schafer et al., 2004) and a reduction in the pro-
portion of protein that is raft associated, rather than a complete 
loss of raft association, based on a sucrose gradient taken from 
whole brains of GalNAc- T−/− compared to WT is observed (Susuki, 
Baba, et al., 2007). In addition, from our immunostaining data, the 
domain that is disrupted at the juxtaparanodal/paranodal edge is 
very minor in size relative to the whole brain. Taken together, it 
is possible that any changes in NF155 raft association were not 
detectable in this study because of an issue of sensitivity. Another 
interpretation for the discrepancy could be that NF155 associates 
with sulfatide rather than ganglioside- enriched rafts (Palavicini 
et al., 2016; Schafer et al., 2004). Therefore, a proportion of NF155 
remains associated with rafts but its localisation, as determined 
by immunostaining, is dispersed due to mislocalisation of the axo– 
glial binding partner Caspr. This could be recovered in a- series 
neuronal rescue despite undetectable Caspr levels due to a differ-
ential stability of protein partners. Previous reports have shown 
that after initial formation, a post- developmental induction of glial 
NF155 knock- down causes a temporal delay in loss of Caspr (Pillai 
et al., 2009), so the reverse is also possible.
In contrast to NF155, we showed that the raft association of 
Caspr was impaired in the Dbl KO and was not improved by neuro-
nal a- series expression in Rescue mice, which aligns with our immu-
nostaining results. It is somewhat surprising that a- series neuronal 
ganglioside expression did not improve axonal Caspr staining or raft 
association, and suggests that Caspr requires stabilisation by b- series 
ganglioside- enriched rafts, at least at the juxtaparanodal/paranodal 
edge. Caspr (and possibly NF155) is likely also restricted to the 
paranode by the axo– glial junction formed by MAG interaction with 
neuronal ganglioside (Pronker et al., 2016) at the juxtaparanodal bor-
der. Thus, Caspr might be stabilised by two mechanisms and it is the 
sum of these protein– protein and protein– lipid interactions that lead 
to stability of the axo– glial junction.
MAG, found on the adaxonal myelin membrane apposing the 
axon, is a key ligand for gangliosides and a vital component for sta-
bility along the length of the axo– glial junction (Bartsch et al., 1989; 
Schnaar et al., 1998; Trapp et al., 1989). Similarities in GalNAc- T−/− and 
MAG−/− age- dependent neurodegenerative phenotypes and the sig-
nificant reduction in MAG protein in the CNS of GalNAc- T−/− mice have 
been noted (McGonigal et al., 2019; Sheikh, Sun, et al., 1999) and sig-
nify the importance of this axo– glial partnership. The main ligands for 
MAG are GT1b and GD1a (Collins et al., 1997; Vinson et al., 2001). In 
the CNS, we showed a reduction in MAG intensity in Dbl KO mice, 
which was partially recovered in Rescue mice. The total amount of 
MAG in the detergent- soluble fraction (non- raft) decreased in both 
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Dbl KO and Rescue mice compared to WT and likely accounts for the 
loss in immunostaining, but lipid raft association was not perturbed 
in any genotype. Extraction studies suggest that MAG is anchored by 
sulfatide containing lipid rafts (Pomicter et al., 2013) which are likely 
unaltered in Dbl KO mice as sulfatide levels do not change in the ab-
sence of gangliosides, and vice versa (Honke et al., 2002; Yamashita 
et al., 2005). It would seem the axo– glial interaction between glial 
MAG and neuronal GT1b and GD1a has been disturbed in the Dbl KO 
mice, accounting for reduced staining intensity along the nerve, and 
GD1a ganglioside alone was insufficient to completely recover this in-
teraction and MAG localisation in Rescue mice. We recently reported 
that sulfatide and gangliosides play independent roles in axo– glial 
stability and it is their combined deficiency that is lethal (McGonigal 
et al., 2019). We proposed a critical role for ganglioside/MAG interac-
tion in the absence of sulfatide that was exacerbated in the absence of 
b- series gangliosides (McGonigal et al., 2019). In the current scenario, 
it seems that the influence of a- series gangliosides is also insufficient 
to suppress the axo– glial disorganisation. Transgenic mice lacking 
key sialylation enzymes resulting in severely diminished expression 
of GD1a and GT1b, had significantly lower brain MAG expression 
(Sturgill et al., 2012). This transgenic mouse shows the significance 
of GT1b to MAG localisation and a normal nervous system. Together 
these data further emphasise the importance of b- series gangliosides 
in axo– glial integrity.
As discussed in our original characterisation of GalNAc- T−/−- 
Tg(neuronal) rescue mice, the activity of normal GalNAc- T enzyme 
in whole brain is not completely restored (Yao et al., 2014), as would 
be expected when adopting an approach using an unrelated pro-
moter to drive expression that is normally highly restricted spatially 
and temporally. As such, it is possible that incomplete restoration of 
Rescue mice to normal might partially be explained by suboptimal 
enzyme activity. Total ganglioside content remains unchanged by ge-
netic alteration due to over- expression of simple gangliosides, which 
could incompletely compensate and only partially restore function. 
Gangliosides are a large and dynamic family of lipids involved in di-
verse functions from cell– cell recognition to neural development. 
There is considerable membrane and subcellular heterogeneity in 
ganglioside expression throughout the body, and additionally there 
is likely a high degree of heterogeneity in lipid raft composition— one 
study, for example, demonstrates distinct separation between GM1- 
and GD3- containing rafts (Vyas et al., 2001). These factors can all 
uniquely influence and contribute to the phenotype and neurode-
generation found in Dbl KO mice. We could not exhaustively study 
every aspect of ganglioside function, so here report on key sites of 
interest in myelinated nerve organisation and maintenance. Overall, 
our findings build upon and enhance our understanding of the role 
of gangliosides in nervous system integrity, with a particular focus 
on the node of Ranvier.
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